RIM
NKTR icon

Rampart Investment Management’s Nektar Therapeutics NKTR Stock Holding History

Rampart Investment Management’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-130
Closed -$36K – 539
2019
Q3 		$36K Sell
130
-61
-32% -$22.4K ﹤0.01% 537
2019
Q2 		$102K Sell
191
-10
-5% -$5.01K 0.01% 514
2019
Q1 		$101K Buy
201
+76
+61% +$45K 0.01% 510
2018
Q4 		$62K Sell
125
-424
-77% -$256K 0.02% 480
2018
Q3 		$109K Sell
549
-184
-25% -$157K 0.05% 385
2018
Q2 		$537K Buy
+733
New +$845K 0.05% 338

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Rampart Investment Management's NKTR Position: Q4 2019 in Review

Rampart Investment Management sold out of Nektar Therapeutics (NKTR) in Q4 2019, closing a stake of 130 shares — an estimated $36K sold.

Rampart Investment Management first reported a position in NKTR in Q2 2018 and held it in 6 quarters. The position peaked at $537K in Q2 2018. 281 funds tracked by Wall St. Rank hold NKTR as of Q4 2019.

  • Rampart Investment Management reported no remaining Nektar Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Rampart Investment Management sold 130 Nektar Therapeutics shares in Q4 2019, an estimated $36K.
  • Rampart Investment Management first reported a position in Nektar Therapeutics in Q2 2018 and held it in 6 quarters.
  • Rampart Investment Management's Nektar Therapeutics position peaked at $537K in Q2 2018.
  • 281 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2019.

Based on Rampart Investment Management's 13F filing for Q4 2019, filed 13 Feb 2020.